Filter
827
Text search:
dosing
Featured
Recommendations
116
New Publications
224
Language
Document type
No document type
465
Guidelines
181
Studies & Reports
93
Manuals
29
Training Material
21
Fact sheets
16
Strategic & Response Plan
12
Situation Updates
4
Resource Platforms
2
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
India
46
South Africa
35
Kenya
27
Tanzania
23
Global
19
Ethiopia
17
Zambia
15
Uganda
11
Nepal
10
Africa
10
Sierra Leone
9
Rwanda
9
Western and Central Europe
9
Nigeria
8
Ghana
8
Malawi
8
Namibia
8
Bangladesh
7
Myanmar / Burma
7
Liberia
6
Zimbabwe
6
Philippines
6
West and Central Africa
5
USA
4
Haiti
4
Syria
4
Cambodia
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
South Sudan
3
Argentina
3
Eswatini/ Swaziland
3
Lesotho
3
Burkina Faso
2
Germany
2
Indonesia
2
Ukraine
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
United Kingdom
2
Guinea
1
Senegal
1
Mali
1
Guinea-Bissau
1
Cameroon
1
Pakistan
1
Iraq
1
Gambia
1
Sudan
1
Benin
1
Peru
1
Brazil
1
Botswana
1
Angola
1
Yemen
1
East and Southern Africa
1
Middle East and North Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
169
Women & Child Health
49
Public Health
28
Capacity Building
26
Key Resources
19
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
114
TB
87
AMR
66
COVID-19
42
Pharmacy
36
Mental Health
32
NCDs
22
NTDs
19
Ebola
14
Caregiver
14
Cholera
9
Conflict
8
Rapid Response
7
Refugee
6
Planetary Health
6
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Natural Hazards
1
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other users. The ultimate aim is to ensure that all health workers are equipped with the requisite compet
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Evidence-to-Decision and Grade tables
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal
...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i
...
This progress report reflects achievements made during the first year of implementation (through December 2016), as countries have taken actions in line with new or existing national strategies. The most recent data on country progress in 2016 are based on country-reported data and country-developed
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
These are integrated National Guidelines 2013 for Prevention and Management of HIV, STIs & Other Blood Borne Infections in accordance with the last guidelines of the World Health Organization (WHO) published in June 2013 and adapted to the Rwandan national context. It thus responds to the need by th
...
A survey of prevention, testing and treatment policies and practices
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell
...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t
...
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care
...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn
...
